What is it about?
Marine-derived omega-3 PUFA intake is inversely associated with risk of all-cause and cardiovascular mortality in renal transplant recipients.
Featured Image
Why is it important?
Up to date there is a critical lack of long-term epidemiological evidence to support the hypothetical beneficial effect of marine-derived omega-3 PUFA intake on long-term survival outcomes in renal transplant recipients. This is the first study aimed to investigated whether marine-derived n-3 PUFA intake is associated with all-cause and cardiovascular (CV) mortality in a large and extensively phenotyped cohort of renal transplant recipients with long-term follow-up.
Perspectives
This study provide further evidence to support the plea for marine-derived omega-3 PUFAs supplementation, particularly in elderly and non-smoking renal transplant recipients.
Dr Camilo G. Sotomayor
University Medical Center Groningen
Read the Original
This page is a summary of: Intake of Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Mortality in Renal Transplant Recipients, Nutrients, April 2017, MDPI AG,
DOI: 10.3390/nu9040363.
You can read the full text:
Resources
Contributors
The following have contributed to this page
